A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation, In-Patient Phase I/II Study to Determine the Safety and Immunogenicity of Ty800 in Healthy Adult Subjects.

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation, In-Patient Phase I/II Study to Determine the Safety and Immunogenicity of Ty800 in Healthy Adult Subjects.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 09 Jun 2011

At a glance

  • Drugs Typhoid vaccine Ty800 (Primary)
  • Indications Typhoid
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 21 May 2007 Status changed from in progress to completed
    • 22 Aug 2006 Status change
    • 22 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top